Home › Funds › Balyasny Asset Management › TERN
Balyasny Asset Management position in TERN
TERNS PHARMACEUTICALS INC
Latest position (Q1 2026)3.89M sh
Reported value held$204.95M
Portfolio Weight0.28%
First reportedQ1 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 367.67K | $4.35M | New |
| Q2 2023 | 583.65K | $5.11M | Add |
| Q4 2023 | 13.85K | $89.91K | New |
| Q2 2024 | 19.16K | $130.49K | New |
| Q1 2025 | 127.89K | $352.97K | New |
| Q4 2025 | 891.90K | $36.03M | New |
| Q1 2026 | 3.89M | $204.95M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TERN
- Vanguard Group 5.52M sh · $223.17M · Q4 2025
- Janus Henderson Group 1.47M sh · $77.51M · Q1 2026